In the pulsating world of healthcare stocks, Elekta Inc. (OTC:EKTAY) has distinguished itself this week with a staggering 129% surge in its momentum score, leaping from 19.90 to 45.67. Elekta, a renowned manufacturer of medical equipment, found its stock trading at $5.86 on Wednesday, unmoved from the previous day’s close but comfortably above its 50-day moving average of $5.01 and its 200-day moving average of $5.11. The RSI at 71.2 signals overbought conditions, while a bullish MACD corroborates the underlying momentum. Despite these promising technical indicators, the company’s Edge score of 0.00 suggests mixed fundamentals.
Hot on Elekta’s heels is Relief Therapeutics Inc. (OTC:RLFTF), which posted a commendable 127% week-over-week increase in its momentum score, rising from 16.45 to 37.40. This Swiss-based biopharmaceutical company focused on clinical-stage drug development, traded at $3.48 on Wednesday, marking a 5.2% slide. Despite this dip, the stock is still hovering above its 200-day moving average of $3.20, although it trails the 50-day moving average of $3.71. The RSI of 48.0 suggests neutral conditions and a bullish MACD intimates positive momentum, contrasting with the company’s Edge score of 0.00 which signifies mixed fundamentals.
